Immunogenicity of Influenza, Pneumococcal and Hepatitis B Vaccines in IBD Patients Treated With Vedolizumab
Clinical trial NCT03056924 · COMPLETED
Trial details
- NCT number
- NCT03056924
- Sponsor
- Boston Medical Center
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-07-05
- Primary completion
- 2019-01-15
- Enrollment
- 173
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.